Trials / Completed
CompletedNCT05450523
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (actual)
- Sponsor
- Qingdao HIGHTOP Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
According to the requirements of the "Technical Guidelines for Clinical Trials of In Vitro Diagnostic Reagents", the first registered product (hereinafter referred to as the assessment reagent) - Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) was tested in clinical institutions. ) for clinical validation trials. Prove that the clinical performance of the assessment reagent meets the requirements of the intended use.
Conditions
Timeline
- Start date
- 2021-12-28
- Primary completion
- 2022-09-07
- Completion
- 2022-09-07
- First posted
- 2022-07-08
- Last updated
- 2023-03-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05450523. Inclusion in this directory is not an endorsement.